Publication | Open Access
SIAXI
114
Citations
23
References
2019
Year
This study provides Class I evidence that incobotulinumtoxinA reduces salivary flow rates in patients with chronic sialorrhea due to PD, atypical parkinsonism, stroke, or TBI.
| Year | Citations | |
|---|---|---|
Page 1
Page 1